Q2 2025 net revenues increased 6.4% to $294 million, or 6.0% on a constant currency basis(1), compared to Q2 2024Q2 2025 net income of $8 million or $0.03 per diluted share, compared to net income of ...

Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the ...

A total of 1 analyst ratings have been received for Sotera Health, with the consensus rating being Outperform. The average one-year price target stands at $13.0, suggesting a potential 17.54% upside.